Regulatory News
Tuesday, March 15, 2016
BRIEF-Kindred Biosciences submits final major new animal drug application technical section for safety for Zimeta
* In target animal safety study, Zimeta, was well tolerated
with no clinically-significant changes when compared to control
horses
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment